Graminex®, L.L.C. is pleased to announce that PollenAid® and Prostanex® have received Natural Product Number (NPN) approval from Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD). This approval confirms that both products meet Health Canada’s rigorous standards for safety, efficacy, and quality for sale as licensed natural health products in Canada.
PollenAid® contains a full clinical dose of Graminex® G63® Flower Pollen Extract™ and is indicated for prostate health, urinary support, and vasomotor activity associated with menopause. Prostanex® combines Graminex® G63® Flower Pollen Extract™ with standardized Saw Palmetto Extract for synergistic prostate and urinary health support.
Health Canada NPN approval is one of the most rigorous natural health product licensing processes in the world. This recognition underscores Graminex’s commitment to regulatory compliance and product quality across global markets.